A Peptide Accelerating the Conversion of Plasminogen Activator Inhibitor-1 to an Inactive Latent State-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Peptide Accelerating the Conversion of Plasminogen Activator Inhibitor-1 to an Inactive Latent State

Published:2008-06-17 Issue:3 Volume:74 Page:641-653
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Mathiasen Lisa,Dupont Daniel M.,Christensen Anni,Blouse Grant E.,Jensen Jan K.,Gils Ann,Declerck Paul J.,Wind Troels,Andreasen Peter A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference60 articles.

1. A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: changing species specificity by substitution of a single residue

2. PAI-1 - A Potential Therapeutic Target in Cancer

3. Solvent Effects on Activity and Conformation of Plasminogen Activator Inhibitor-1

4. The plasminogen activation system in tumor growth, invasion, and metastasis

5. The urokinase-type plasminogen activator system in cancer metastasis: A review

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors;Cancer Letters;2023-04

2. Role of Fibrinolytic Mechanisms in Breast Cancer Diagnosis, Prognosis, and Treatment;Breast Cancer: From Bench to Personalized Medicine;2022

3. A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?;International Journal of Molecular Sciences;2021-03-08

4. Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition;Frontiers in Cardiovascular Medicine;2020-12-22

5. Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications;Frontiers in Oncology;2018-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3